MAPK1 and myeloid sarcoma: However, in the presence of genetic variants that affect other genes within the axon signaling pathway (e.g., MS-associated eGene ERK), EPHA6 disruption could propagate through the axon signaling pathway to trigger the risk pathway for MS.